6 research outputs found
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
Efficacy and safety of switching from basal insulin to once-daily insulin degludec/insulin aspart in Japanese patients with inadequately controlled type 2 diabetes: A 4-week, randomized, open-label, treat-to-target study
Impact of diabetes duration on hypoglycaemia in patients with type 2 diabetes treated with insulin glargine or NPH insulin
Utilities and disutilities for attributes of injectable treatments for type 2 diabetes
Utilities, Type 2 diabetes, Injection, Dose frequency, Patient preference, Standard gamble, I00, I10, I19,